title: Effect of oral potassium supplements on urinary kallikrein excretion in Sheehan's syndrome.
authors.forename: J M
authors.initials: JM
authors.lastname: López
authors.forename: D
authors.initials: D
authors.lastname: Mahana
authors.forename: J A
authors.initials: JA
authors.lastname: Rodríguez
authors.forename: P
authors.initials: P
authors.lastname: Michaud
authors.forename: E
authors.initials: E
authors.lastname: Arteaga
authors.forename: C
authors.initials: C
authors.lastname: Fardella
mesh_terms: D000328:Adult; D000368:Aged; D000450:Aldosterone / Q000652:urine; D000804:Angiotensin II / Q000037:antagonists & inhibitors; D002216:Captopril / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007018:Hypopituitarism / Q000652:urine*; D007610:Kallikreins / Q000652:urine*; D008875:Middle Aged; D011188:Potassium / Q000008:administration & dosage*
chemical_list: D000804:Angiotensin II; D000450:Aldosterone; D002216:Captopril; D007610:Kallikreins; D011188:Potassium; D006854:Hydrocortisone